I often get asked why the adoption of digital therapeutics (DTx) is so slow, and if they will ever take off. It’s a good question, as there are both opportunities and challenges in each area of DTx adoption. Let’s now take a look at 9 key challenges and opportunities, but first up, a short definition of DTx:
